Evidence mapPaperPMID 41594666Full record

ArticleBiomolecules2026

Comparison of In Vitro Multiple Physiological Activities of Cys-Tyr-Gly-Ser-Arg (CYGSR) Linear and Cyclic Peptides and Analysis Based on Molecular Docking.

Ga-Hyun Kim, Jeong-Eun Bang, Bo-Mi Kim

Abstract readComparative Study
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ga-Hyun KimDepartment of Chemical Engineering, Wonkwang University, Iksan-si 54538, Jeollabuk-do, Republic of Korea.ORCID 0009-0009-0219-4586
Jeong-Eun BangDepartment of Chemical Engineering, Wonkwang University, Iksan-si 54538, Jeollabuk-do, Republic of Korea.ORCID 0009-0000-1383-2672
Bo-Mi KimDepartment of Chemical Engineering, Wonkwang University, Iksan-si 54538, Jeollabuk-do, Republic of Korea.ORCID 0009-0009-8546-7980

Funding

Regional Innovation System and Education (RISE) program through the Jeonbuk RISE Center, funded by the Ministry of Education (MOE) and Jeonbuk State, Republic of Korea (2025-RISE-13-WKU) and the "Glocal 30" Project. Supported by the Ministry of Education 2025-RISE-13-WKU
6 · The paper itself

Abstract

Peptide cyclization is a strategy to improve biological stability and functional activity, but direct comparison between linear and cyclic peptides with the same sequence is still limited. In this study, linear (L-CR5) and cyclic (C-CR5) forms were synthesized, and biological functions such as antioxidant, whitening, and anti-wrinkle activity were compared and evaluated. C-CR5 showed about 22.3 times of DPPH radical scavenging activity, which was significantly stronger than L-CR5, and tyrosinase inhibition increased rapidly in C-CR5 to reach inhibition of 95% or more, whereas L-CR5 showed only moderate activity in the same range (about 6.5 times). MMP-1 expression in the evaluation of anti-wrinkle activity did not show a decreasing trend in L-CR5 at all, while C-CR5 showed an anti-wrinkle effect, which was reduced by about 92.8% at 400 μg/mL. As a result of molecular docking analysis, C-CR5 exhibited lower MolDock scores than L-CR5 toward both tyrosinase and MMP-1, indicating a potentially higher binding affinity and improved binding stability. This is expected to be due to reduced structural flexibility and optimized residue directions (especially Tyr and Arg). These results indicate that peptide cyclization is an example of enhanced functional bioactivity of CYGSR and provides a positive case for the structure-activity relationship.

Indexed as

Molecular Docking SimulationOligopeptidesPeptides, CyclicAntioxidantsFree Radical ScavengersMatrix Metalloproteinase 1Monophenol MonooxygenaseAntioxidantsFree Radical ScavengersMatrix Metalloproteinase 1Monophenol MonooxygenaseOligopeptidesPeptides, CyclicCR5 peptidecyclic peptideDPPH radical scavenginglinear peptideMMP-1 inhibitionmolecular dockingtyrosinase inhibition

Identifiers

PMID41594666
PMCPMC12839123

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.